Lithium has been used for over half a century for the treatment of bipolar disorder as the
archetypal mood stabilizer, and has a wealth of empirical evidence supporting its efficacy in …

Objectives. These guidelines are based on a first edition that was published in 2004, and
have been edited and updated with the available scientific evidence up to October 2012 …

Objective: To describe the development and validation of the Clinical Global Impression–
Schizophrenia (CGI‐SCH) scale, designed to assess positive, negative, depressive and …

Objective: To identify drugs associated with the complaint of dry mouth. Materials and
Methods: MEDLINE was searched for papers 1980–2002 using keywords, oral, mouth …

Bipolar (manic-depressive) disorder is a common and severe illness. It is also potentially
fatal as a result of accidents and increased mortality associated with comorbid substance …

Objectives: Although clinically highly relevant, the recognition and treatment of bipolar mixed
states has played only an underpart in recent guidelines. This WFSBP guideline has been …

Abstract Objectives The 2018 Canadian Network for Mood and Anxiety Treatments
(CANMAT) and International Society for Bipolar Disorders (ISBD) guidelines provided …

A wide spectrum of drugs can sometimes give rise to numerous adverse orofacial
manifestations, particularly dry mouth, taste disturbances, oral mucosal ulceration, and/or …

These updated guidelines are based on a first edition that was published in 2003, and have
been edited and updated with the available scientific evidence until end of 2008. Their …

Reelin and glutamic acid decarboxylase (GAD) 67 expressed by cortical γ-aminobutyric acid-
ergic interneurons are down-regulated in schizophrenia. Because epidemiological studies …